Venlafaxine reduces hot flashes in hormone receptor-positive breast cancer patients receiving tamoxifen: a prospective single-arm, open-label trial | Synapse
March 3, 2026Open Access
Venlafaxine reduces hot flashes in hormone receptor-positive breast cancer patients receiving tamoxifen: a prospective single-arm, open-label trial
Key Points
Hot flashes significantly decreased with venlafaxine among patients in the trial, indicating effective symptom relief.
Patients experienced a notable reduction of over 50% in hot flash frequency after treatment with venlafaxine.
This was a prospective single-arm trial assessing the impact of venlafaxine on women undergoing tamoxifen therapy.
These findings highlight the potential of venlafaxine as an effective intervention for managing hot flashes during tamoxifen treatment.